Alcon AG reported $2.72B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
AstraZeneca USD 16.21B 830M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
Essilor EUR 14.82B 351M Jun/2026
Fresenius EUR 5.88B 70M Sep/2026
Fresenius Medical Care EUR 4.94B 80M Sep/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
GRIFOLS EUR 2.04B 170M Sep/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.63B 200M Sep/2026
Novartis USD 14.52B 112M Sep/2026
Philips EUR 4.4B 40M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 14.44B 2.49B Sep/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
Sonova Holding CHF 1.82B 216.8M Dec/2025
UCB EUR 4.25B 764M Dec/2025